1
|
Ajani AA, Olanrewaju FO, Oninla OA, Ibigbami O, Mosaku SK, Onayemi OE, Olasode O. Psychodermatological Disorders in Patients With Primary Psychiatric Conditions: Cross-Sectional Study. JMIR Dermatol 2023; 6:e47769. [PMID: 37782534 PMCID: PMC10580141 DOI: 10.2196/47769] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/04/2023] [Revised: 08/23/2023] [Accepted: 08/30/2023] [Indexed: 10/03/2023] Open
Abstract
BACKGROUND Psychodermatological disorders (PDs) and their associations with mental health problems are one of the most frequent research themes in dermatology outpatient settings. Surprisingly, very few studies have been conducted to evaluate PDs among patients with primary psychiatric conditions. As such, the relationship between preexisting psychiatric conditions and comorbid PDs is underrepresented in the literature. OBJECTIVE This study examined the prevalence and distribution of PDs among adults with primary psychiatric conditions and determined their association with underlying psychiatric diagnoses. METHODS We conducted a cross-sectional analysis at a tertiary health care facility in southwestern Nigeria. Comorbid PDs were identified and classified using preexisting classification systems. A bivariate analysis was conducted to determine the association between PDs and underlying psychiatric conditions. The level of statistical significance was set at P<.05. RESULTS The study included 107 patients with mental health disorders, of whom 64 (59.8%) were female. The mean age of the patients was 40.73 (SD 13.08) years. A total of 75 (75/107, 70%) patients had at least one comorbid PD. The prevalence of PDs was highest in patients with affective disorders (15/20, 75%) and least in those with schizophrenia (45/66, 68%). PDs associated with delusions or hallucinations and somatoform symptoms were 9 and 13 times more frequent in patients with anxiety disorders compared to those with other psychiatric conditions (P=.01; odds ratio [OR] 9.88, 95% CI 1.67-58.34 and P=.003; OR 13.13, 95% CI 2.34-73.65), respectively. In contrast, patients with schizophrenia were significantly less likely to be diagnosed with dermatoses resulting from delusions or hallucinations (P=.002; OR 0.04, 95% CI 0.00-0.75). A weak but significant negative association was also found between psychophysiological PDs and anxiety disorders (ϕ=-0.236; P=.02). CONCLUSIONS This study provides important insights into the overwhelming burden of psychodermatological conditions in patients with mental health disorders and specific associations with underlying psychiatric diagnosis.
Collapse
Affiliation(s)
- Atinuke Arinola Ajani
- Department of Dermatology and Venereology, Obafemi Awolowo University, Ile Ife, Nigeria
| | | | | | - Olanrewaju Ibigbami
- Department of Dermatology and Venereology, Obafemi Awolowo University, Ile Ife, Nigeria
| | | | | | - Olayinka Olasode
- Department of Dermatology and Venereology, Obafemi Awolowo University, Ile Ife, Nigeria
| |
Collapse
|
2
|
Rinaldi A, Rinaldi C, Coelho Pereira JA, Lotti Margotti M, Bittencourt MN, Barcessat ARP, Fontani V, Rinaldi S. Radio electric asymmetric conveyer neuromodulation in depression, anxiety, and stress. Neuropsychiatr Dis Treat 2019; 15:469-480. [PMID: 30858704 PMCID: PMC6387613 DOI: 10.2147/ndt.s195466] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/11/2022] Open
Abstract
BACKGROUND The purpose of this study was to assess the efficacy of specific neuromodulation treatments performed with radio electric asymmetric conveyer (REAC) technology in the treatment of the symptomatic triad depression, anxiety, and stress by the use of a specific psychometric test such as the Depression Anxiety Stress Scale-42 items (DASS-42) version, which assesses simultaneously the severity of expression of this triad. PATIENTS AND METHODS The design of this study was planned to compare two populations that performed DASS-42 test twice within a similar period of time. The first population performed the first DASS test before the treatment and the second test about 3 months later, at the end of two specific REAC neuromodulation treatments, neuropostural optimization (NPO) and neuropsychophysical optimization (NPPO), that have previously shown an efficacy in the treatment of depression, anxiety and stress. The second population (untreated), used as the randomized control group, consisted of a similar group by gender and age, who performed the DASS-42 test in an online platform twice, with an interval of about 3 months between the first and second tests, similar to the interval between the two tests in the treated group. RESULTS The comparison between the treated group and the control group points out the REAC treatment efficacy in improving the quality of life. At the second DASS-42 test, self-administered about 3 months after the treatments, treated patients were positioned on average values of much milder severity in all the three clusters, depression, anxiety, and stress, while in untreated patients there was no significant difference between the mean values of the first and second DASS tests. CONCLUSION The results obtained in this study, evaluated with the DASS-42 test, confirm that REAC-NPO and REAC-NPPO neuromodulation treatments can be useful tools for the clinical treatment of depression, anxiety, and stress, as already proven by previous results evaluated with different psychometric tests.
Collapse
Affiliation(s)
- Arianna Rinaldi
- Department of Neuro Psycho Physio Pathology and Neuro Psycho Physical Optimization, Rinaldi Fontani Institute, Florence, Italy, .,Research Department, Rinaldi Fontani Foundation, Florence, Italy,
| | - Chiara Rinaldi
- Department of Neuro Psycho Physio Pathology and Neuro Psycho Physical Optimization, Rinaldi Fontani Institute, Florence, Italy, .,Research Department, Rinaldi Fontani Foundation, Florence, Italy,
| | | | - Matteo Lotti Margotti
- Department of Neuro Psycho Physio Pathology and Neuro Psycho Physical Optimization, Rinaldi Fontani Institute, Florence, Italy, .,Research Department, Rinaldi Fontani Foundation, Florence, Italy,
| | | | | | - Vania Fontani
- Department of Neuro Psycho Physio Pathology and Neuro Psycho Physical Optimization, Rinaldi Fontani Institute, Florence, Italy, .,Research Department, Rinaldi Fontani Foundation, Florence, Italy,
| | - Salvatore Rinaldi
- Department of Neuro Psycho Physio Pathology and Neuro Psycho Physical Optimization, Rinaldi Fontani Institute, Florence, Italy, .,Research Department, Rinaldi Fontani Foundation, Florence, Italy,
| |
Collapse
|
3
|
Abstract
In this study, we examined the prevalence of 14 psychophysiological disorders among 114 opioid-dependent individuals (a sample that previously evidenced high rates of borderline personality) as well as the relationship between these disorders and borderline personality. In the aftermath of analyses, only migraine headaches (28.9%) and chronic pain (33.3%) demonstrated relatively high frequency rates in this sample. Only migraine headaches showed a significant relationship with the diagnosis of borderline personality symptoms. In conclusion, in an opioid-dependent population, the prevalence of psychophysiological disorders appears to be rather unremarkable.
Collapse
Affiliation(s)
- Randy A Sansone
- Departments of Psychiatry and Internal Medicine, Wright State University School of Medicine, Dayton, OH, USA
| | | | | |
Collapse
|